Tandem Diabetes Care reports Q1 2022 earnings; no specifics in filing

TANDEM DIABETES CARE INC

2022-Q1 EPS reported -$0.23 revenue$175,907,000

Announced financial results for the quarter ended March 31, 2022 on May 4, 2022.
Press release containing detailed figures is not included in this submission.
No guidance or non-earnings material items disclosed in the filing body.

item 2.02 item 9.01

TANDEM DIABETES CARE INC filing history →

Source: SEC EDGAR

accession 0001438133-22-000059

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.